Copper(II) complexes with N′-methylsarcosinamide selective for human bladder cancer cells

Selected polyoxopalladates as promising and selective antitumor drug candidates

Polyoxo-noble-metalates (PONMs), a class of molecular noble metal-oxo nanoclusters that combine features of both polyoxometalates and noble metals, are a promising platform for the development of next-generation antitumor metallodrugs. This study aimed to evaluate the antitumor potential against human neuroblastoma cells (SH-SY5Y), as well as toxicity towards healthy human peripheral blood cells (HPBCs), of five polyoxopalladates(II): (Na₈[Pd₁₃As₈O₃₄(OH)₆]·42H₂O (Pd₁₃), Na₄[SrPd₁₂O₆(OH)₃(PhAsO₃)₆(OAc)₃]·2NaOAc·32H₂O (SrPd₁₂), Na₆[Pd₁₃(AsPh)₈O₃₂]·23H₂O (Pd₁₃L), Na₁₂[SnO₈Pd₁₂(PO₄)₈]·43H₂O (SnPd₁₂), and Na₁₂[PbO₈Pd₁₂(PO₄)₈]·38H₂O (PbPd₁₂)), as the largest subset of PONMs. A pure inorganic, Pd₁₃, was found as the most potent and selective antineuroblastoma agent with IC₅₀ values (µM) of 7.2 ± 2.2 and 4.4 ± 1.2 for 24 and 48 h treatment, respectively, even lower than cisplatin (28.4 ± 7.4 and 11.6 ± 0.8). The obtained IC₅₀ values (µM) for 24/48 h treatment with SrPd₁₂ and Pd₁₃L were 75.8 ± 6.7/76.7 ± 22.9 and 63.8 ± 3.6/21.4 ± 10.8, respectively, whereas SnPd₁₂ and PbPd₁₂ did not remarkably affect the SH-SY5Y viability (IC₅₀ > > 100 µM). Pd₁₃ caused depolarisation of inner mitochondrial membrane prior to superoxide ion hyperproduction, followed by caspase activation, DNA fragmentation and cell cycle arrest, all hallmarks of apoptotic cell death, and accompanied by an increase in acidic vesicles content, suggestive of autophagy induction. Importantly, Pd₁₃ demonstrated the antitumor effect at concentrations not cytogenotoxic for normal HPBCs. On the contrary, SrPd₁₂ and Pd₁₃L at concentrations ≥ 1/3 IC₅₀ (24 h) decreased HPBC viability and increased % tail DNA up to 42% and 3.05 times, respectively, related to control. SnPd₁₂ and PbPd_12, previously confirmed promising antileukemic agents, did not exhibit cytogenotoxicity to HPBCs, and thus could be regarded as tumor cell specific and selective drug candidates.

Stereochemistry of Hexacoordinated Zn(II), Cu(II), Ni(II), and Co(II) Complexes with Iminodiacetamide Ligands

Metal complexes of iminodiacetamide (imda) ligands and metal ions Zn(II), Cu(II), Ni(II), and Co(II) were prepared using eight imda ligands (L1-L8) substituted with groups of different steric and electronic properties on the central amine N atom (H atom, methyl, isopropyl, and benzyl) and the para position of the phenyl rings (nitro and dimethylamino). The effect of these substituents on the stoichiometry (ML and ML₂), geometry, and stereochemistry (mer, trans-fac, cis-fac) of the complexes was studied in the solid state, in solution, and by density functional theory calculations. Single-crystal and powder X-ray diffraction, thermogravimetry, and IR spectroscopy showed that in the solid state imda ligands preferentially form trans-fac ML₂ complexes, with the exception of the cis-fac complex 7_Zn. NMR spectroscopy of diamagnetic Zn(II) and paramagnetic Co(II) complexes revealed the formation of both ML and ML₂ complexes in solution, which was also confirmed by UV-vis titrations. Variable-temperature NMR was used to study the effect of the substituent on the central amine N atom on the Zn-N bond strength and nitrogen inversion. The relative stabilities of the isomers were rationalized by computations and the optimized structures used for geometry analysis.